title: Effects of handling and vehicle injections on adrenocorticotropic and corticosterone concentrations in Sprague-Dawley compared with Lewis rats.
abstract: The hypothalamic-pituitary-adrenal (HPA) axis is a key factor in the trajectory of the addiction-like cycle (a pattern of behavior characterized by escalating drug use, withdrawal, and relapse) in preclinical and clinical studies. Concentrations of HPA hormones change in laboratory animals in response to standard experimental procedures, including handling and vehicle injections. We compared HPA activity in adult male Lewis (inbred) and Sprague-Dawley (outbred) rats, 2 common strains in rodent models of addiction, after different schedules of handling and saline injections, to explore the extent to which HPA responses differ by strain and whether interindividual differences underlie addiction vulnerability. The 4 treatment conditions were no, short, or long handling and saline injections. In handled groups, rats were handled for 1 to 2 min for 3 times daily and were euthanized after 7 d (short handling) or 14 d (long handling). The injection schedule in the saline injection group mimicked that in a model of binge-like cocaine exposure. Across all treatment groups, concentrations of adrenocorticotropic hormone were higher in Sprague-Dawley than in Lewis rats. In Sprague-Dawley rats, corticosterone concentrations decreased after continued handling but remained constant in Lewis rats. Interindividual variability in hormone levels was greater in Sprague-Dawley than Lewis rats, although corticosterone variability decreased after continued handling. Prolactin did not differ between groups of either Sprague-Dawley and Lewis rats before or after handling. This study underscores the importance of prolonged handling before experimenter-provided drug-administration paradigms and of strain-associated differences that may affect study outcomes.
authors: The Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, New York, USA. kreek@rockefeller.edu.
authors: Molly
authors: M
authors: Deutsch-Feldman
authors: The Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, New York, USA.
authors: Roberto
authors: R
authors: Picetti
authors: The Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, New York, USA; Mount Sinai School of Medicine, New York, New York, USA.
authors: Katharine
authors: K
authors: Seip-Cammack
authors: The Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, New York, USA.
authors: Yan
authors: Y
authors: Zhou
authors: The Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, New York, USA.
authors: Mary Jeanne
authors: MJ
authors: Kreek
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000097:blood; D000818:Animals; D003345:Corticosterone / Q000097:blood; D006234:Handling, Psychological; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D007274:Injections, Intraperitoneal / Q000662:veterinary*; D008297:Male; D010913:Pituitary-Adrenal System; D011388:Prolactin / Q000097:blood; D051381:Rats; D011917:Rats, Inbred Lew / Q000502:physiology*; D017207:Rats, Sprague-Dawley / Q000502:physiology*; D013045:Species Specificity
chemical_list: D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D003345:Corticosterone
references: Lab Anim. 2000 Oct;34(4):372-8
references: 11072857
references: Neurosci Lett. 2013 Mar 1;536:47-51
references: 23313592
references: Psychoneuroendocrinology. 2002 Jan-Feb;27(1-2):35-69
references: 11750769
references: J Neurobiol. 2003 Jan;54(1):283-311
references: 12486710
references: J Physiol Pharmacol. 2003 Sep;54(3):449-59
references: 14566082
references: Endocr Rev. 1985 Fall;6(4):564-89
references: 2866952
references: Life Sci. 1986 Aug 4;39(5):471-5
references: 3090393
references: Trends Pharmacol Sci. 1989 Feb;10(2):78-83
references: 2655243
references: J Neurosci. 1991 Aug;11(8):2321-31
references: 1908006
references: J Neuroimmunol. 1991 Dec;35(1-3):53-64
references: 1955572
references: J Neural Transm Gen Sect. 1992;90(3):163-9
references: 1285948
references: Psychoneuroendocrinology. 1996 Jan;21(1):17-24
references: 8778900
references: J Pharmacol Exp Ther. 1996 Oct;279(1):351-8
references: 8859013
references: J Anim Sci. 1997 Jan;75(1):249-57
references: 9027573
references: Neuroendocrinology. 1997 May;65(5):360-8
references: 9158068
references: Lab Anim Sci. 1997 Aug;47(4):376-85
references: 9306311
references: Pharmacol Biochem Behav. 1998 Jun;60(2):593-9
references: 9632245
references: Drug Alcohol Depend. 1998 Jun-Jul;51(1-2):23-47
references: 9716928
references: Science. 1999 Jun 4;284(5420):1670-2
references: 10356397
references: Brain Res Mol Brain Res. 2005 Jun 13;137(1-2):258-62
references: 15950784
references: Genes Brain Behav. 2005 Oct;4(7):412-9
references: 16176387
references: Physiol Behav. 2006 Nov 30;89(4):598-610
references: 16935312
references: Synapse. 2007 Oct;61(10):820-6
references: 17621646
references: Am J Psychiatry. 2007 Aug;164(8):1149-59
references: 17671276
references: Neuron. 2008 Jul 10;59(1):11-34
references: 18614026
references: Ann N Y Acad Sci. 2008 Oct;1141:105-30
references: 18991954
references: Endocrinology. 2009 Jun;150(6):2934-9
references: 19213839
references: Nat Rev Neurosci. 2009 Jun;10(6):397-409
references: 19469025
references: Neurobiol Learn Mem. 2009 Sep;92(2):215-24
references: 18667167
references: Psychopharmacology (Berl). 2010 Aug;211(3):313-23
references: 20559822
references: Lab Anim (NY). 2011 Apr;40(4):119-28
references: 21427691
references: Noise Health. 2011 Jul-Aug;13(53):286-91
references: 21768732
references: Pharmacol Rep. 2012;64(1):64-9
references: 22580521
references: J Neurosci. 2012 Jun 6;32(23):8074-83
references: 22674282
references: Brain Res. 2012 Aug 30;1471:1-12
references: 22759906
references: J Am Assoc Lab Anim Sci. 2012;51(5):548-53
references: 23312082
references: Cell Mol Neurobiol. 2001 Feb;21(1):91-100
references: 11440201